These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1670506)

  • 1. [Chemotherapy-induced emesis and serotonin antagonists].
    Jantunen I; Johansson R
    Duodecim; 1991; 107(14):1112-5. PubMed ID: 1670506
    [No Abstract]   [Full Text] [Related]  

  • 2. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H; Celik I
    Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study.
    Yalçin S; Tekuzman G; Baltali E; Ozişik Y; Barişta I
    Am J Clin Oncol; 1999 Feb; 22(1):94-6. PubMed ID: 10025391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
    Morrow GR; Hickok JT; Rosenthal SN
    Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic therapy in managed care oncology: roundtable discussion.
    Gerbino PP; Goldsmith M; Kenney JT; Lindley C; Nolte J; Quan W; Reich PR
    Med Interface; 1996 Sep; Suppl C():16-35. PubMed ID: 10161507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.
    Hesketh P
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):19-23. PubMed ID: 7570050
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Cunningham RS
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
    Hainsworth JD
    Semin Surg Oncol; 1993; 9(3):279-84. PubMed ID: 8516617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
    Jordan K; Hinke A; Grothey A; Voigt W; Arnold D; Wolf HH; Schmoll HJ
    Support Care Cancer; 2007 Sep; 15(9):1023-33. PubMed ID: 17205281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting nausea in the '90s: more and better anti-emetics can help.
    Saphir A
    J Natl Cancer Inst; 1997 Sep; 89(17):1252-5. PubMed ID: 9293911
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
    Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron to prevent vomiting after cancer chemotherapy.
    Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study.
    Jantunen IT; Muhonen TT; Kataja VV; Flander MK; Teerenhovi L
    Eur J Cancer; 1993; 29A(12):1669-72. PubMed ID: 8398291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
    Perez EA
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):1-2. PubMed ID: 7570049
    [No Abstract]   [Full Text] [Related]  

  • 19. '... setron': are 5-HT3 receptor antagonists different?
    Aapro MS
    Eur J Cancer; 1993; 29A(12):1655. PubMed ID: 8398287
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
    Neufeld SM; Newburn-Cook CV
    J Neurosurg Anesthesiol; 2007 Jan; 19(1):10-7. PubMed ID: 17198095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.